Patent Assignment
Reel/Frame 060206/0083
Change of Name
Recorded: 2022-05-27
Pages: 11
Assignor
SUMITOMO DAINIPPON PHARMA CO., LTD.
Executed: 2022-04-01
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 5410045, JAPAN
Covered Properties
(3)
SUBSTITUTED NAPHTHO[2,3-b]FURANS AS WATER-SOLUBLE PRODRUGS FOR PREVENTING AND/OR TREATING CANCER
SUBSTITUTED NAPHTHO[2,3-b]FURANS AS WATER-SOLUBLE PRODRUGS FOR PREVENTING AND/OR TREATING CANCER
Process for producing a hydrate of a hydrochloride salt of 2,2'-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acid
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 14, 2017
From: BAN, HITOSHI; KAMIOKA, SEIJI; SAWAYAMA, YUSUKE; LI, CHIANG JIA
To: BOSTON BIOMEDICAL, INC.; SUMITOMO DAINPPON PHARMA CO., LTD.
Reel/Frame 044443/0854 →
Corrective Assignment to Correct the Application Number 15561915 Should Be 15561828 Previously Recorded on Reel 044443 Frame 0854. Assignor(S) Hereby Confirms the Application Number 15561915 Should Be 15561828.
Dec 21, 2017
From: BAN, HITOSHI; KAMIOKA, SEIJI; SAWAYAMA, YUSUKE; LI, CHIANG JIA
To: BOSTON BIOMEDICAL. INC.; SUMITOMO DAINIPPON PHARMA CO.. LTD.
Reel/Frame 044942/0046 →
Assignment of Assignor's Interest
Mar 5, 2018
From: BAN, HITOSHI; KAMIOKA, SEIJI; SAWAYAMA, YUSUKE; LI, CHIANG JIA
To: BOSTON BIOMEDICAL, INC.; SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 045486/0644 →
Change of Name
Nov 6, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 054349/0213 →
Change of Name
May 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 060390/0050 →